What happened: Researchers in the UK are creating a vaccine targeting the rare Bundibugyo Ebola strain, which kills about one-third of those infected. The vaccine could be ready for trials within months.
Why it matters:
- This strain currently has no proven vaccine, posing a significant health risk.
- A successful vaccine could protect vulnerable populations and improve outbreak control.
MNN Take: Developing a vaccine for the Bundibugyo Ebola strain is a crucial step in addressing a deadly virus with limited treatment options, potentially reducing fatalities in future outbreaks.
Sources: BBC Health (Lifestyle)